Grants and Contributions:
Title:
Innovation and Biomanufacturing Centre project
Agreement Number:
819748
Agreement Value:
$62,000,000.00
Agreement Date:
Feb 13, 2025 - Jun 1, 2047
Description:
This project will support the establishment of an innovation research and development (R&D) centre and a commercial scale, good manufacturing practices (GMP) manufacturing facility in Edmonton, Alberta for the production of novel genetic medicines.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
This investment will help strengthen pandemic preparedness and increase domestic biomanufacturing capacity of genetic medicines used to help treat diseases, including cancers, infectious diseases, and neurodegenerative diseases.
Location:
Edmonton, Alberta, CA T5J4P6
Reference Number:
033-2024-2025-Q4-819748
Agreement Type:
Other transfer payment
Report Type:
Grants and Contributions
Recipient Business Number:
816561112
Recipient Type:
For-profit organization
Additional Information:
This is a partially unconditionally repayable contribution.
Recipient's Operating Name:
Entos Pharmaceuticals Inc.
Recipient's Legal Name:
Entos Pharmaceuticals Inc.
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
SIF Stream2- Growth
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
325410